Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning ladies and gentlemen and welcome to the Avanos Second Quarter 2025 earnings conference call. At this time all lines are in listen only mode. Following the presentation we will conduct a question and answer session and if at any time during this call you require immediate assistance please press star zero for the operator. I would now like to turn the conference over to Scott Calavan, Chief Financial Officer, please go ahead sir. Good morning everyone and thanks for joining us. It's my pleasure to welcome you to Avanos 2025 Second Quarter earnings conference call. Presenting today will be Dave Pasitti, CEO who will kick off the call by sharing a few leadership updates. Dave will then provide a high level overview of our Second Quarter results before turning it over to Jason Pickett who has been serving as our interim CFO. Jason will share additional details on these topics, provide an overview of our financial results and affirm our 2025 planning assumptions inclusive of the impact of tariffs. We will finish the call with Q&A. A presentation for today's call is available on the investor section of our website Avanos.com. As a reminder our comments today contain forward looking statements related to the company, our expected performance and current economic conditions including risk related to ongoing tariff negotiations and our industry. No assurance can be given as to future financial results. Actual results could differ materially from those in the forward looking statements. For more information about forward looking statements and the risk factors that could influence future results, please see today's press release and risk factors described in our filings with the SEC. Additionally, we will be referring to adjusted results and outlook. The press rel...